Surveillance and characterization of carbapenem-resistant Enterobacter cloacae complex from China, 2015–2018 [PDF]
Background The carbapenem-resistant Enterobacter cloacae (CREC) have become a global health concern. However, our understanding of its epidemiological trends and resistance mechanisms still needs to be improved. Methods Ninety-one non-repetitive clinical
Kun Ye +5 more
doaj +4 more sources
IMI-Type Carbapenemase-Producing Enterobacter cloacae Complex, France and Overseas Regions, 2012–2022 [PDF]
We characterized a collection of IMI-like–producing Enterobacter spp. isolates (n = 112) in France. The main clone corresponded to IMI-1–producing sequence type 820 E. cloacae subspecies cloacae that was involved in an outbreak.
Cécile Emeraud +11 more
doaj +4 more sources
Some virulence genes are associated with antibiotic susceptibility in Enterobacter cloacae complex [PDF]
Background Enterobacter cloacae complex (ECC) including different species are isolated from different human clinical samples. ECC is armed by many different virulence genes (VGs) and they were also classified among ESKAPE group by WHO recently.
Fatemeh Mosaffa +3 more
doaj +4 more sources
Study on collateral sensitivity of tigecycline to colistin-resistant Enterobacter cloacae complex [PDF]
The past decade has witnessed the emergence and spread of carbapenem-resistant Enterobacter cloacae complex (CRECC), presenting a significant clinical challenge and urgently demanding new treatment strategies against antimicrobial resistance (AMR).
Kaixin Yu +11 more
doaj +4 more sources
High prevalence of colistin heteroresistance in specific species and lineages of Enterobacter cloacae complex derived from human clinical specimens [PDF]
Background Colistin (CST) is a last-line drug for multidrug-resistant Gram-negative bacterial infections. CST-heteroresistant Enterobacter cloacae complex (ECC) has been isolated.
Shota Fukuzawa +9 more
doaj +2 more sources
Cefazolin and imipenem enhance AmpC expression and resistance in NagZ-dependent manner in Enterobacter cloacae complex [PDF]
Background Enterobacter cloacae complex (ECC) is a common opportunistic pathogen and is responsible for causing various infections in humans. Owing to its inducible chromosomal AmpC β-lactamase (AmpC), ECC is inherently resistant to the 1st- and 2nd ...
Xianggui Yang +6 more
doaj +2 more sources
Effect of sub-inhibitory tigecycline (½-MIC) on AcrAB-TolC and mar/ram/sox regulatory genes in Enterobacter cloacae complex isolates [PDF]
The global rise of antimicrobial resistance (AMR) in Enterobacterales, including the Enterobacter cloacae complex, is narrowing treatment options.
Lukasz Korczak +4 more
doaj +2 more sources
Transcriptomic analysis of tigecycline-induced colistin collateral sensitivity in carbapenem-resistant Enterobacter cloacae complex [PDF]
Utilizing treatment strategies based on collateral sensitivity (CS) represents a promising approach to suppressing antibiotic resistance. Although the mechanism of CS between numerous drugs has been researched, the mechanism of CS between tigecycline and
Youtao Liang +10 more
doaj +2 more sources
Precise species identification and whole-genome sequencing analysis of Enterobacter cloacae complex causing bloodstream infections in China [PDF]
The Enterobacter cloacae complex (ECC) is one of the major causes of hospital-acquired infections. However, achieving accurate species identification and comprehensive resistance profiling remains difficult in clinical practice, with a limited ...
Yanbing Li +6 more
doaj +2 more sources
Infections caused by clonal spread of metallo-beta-lactamase-producing Enterobacter cloacae complex isolates at a southern Taiwan hospital [PDF]
Carbapenem-resistant Enterobacter cloacae complex (ECC) has become a clinically important pathogen with increased incidence worldwide in recent years. In Taiwan, IMP-8 accounted for most carbapenemase produced by ECC in earlier studies.
Cong-Tat Cia +6 more
doaj +2 more sources

